Category:Théophile OHLMANN

Théophile OHLMANN

Executive Summary

Théophile OHLMANN is an inventor who has filed 3 patents. Their primary areas of innovation include from viruses (3 patents), Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof (preparing medicinal viral antigen or antibody compositions, e.g. virus vaccines, (3 patents), MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media (3 patents), and they have worked with companies such as Institut National De La Sante Et De La Recherche Medicale (INSERM) (3 patents). Their most frequent collaborators include (3 collaborations), (3 collaborations).

Patent Filing Activity

Technology Areas

List of Technology Areas

• C07K14/005 (from viruses): 3 patents
• C12N7/00 (Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof (preparing medicinal viral antigen or antibody compositions, e.g. virus vaccines,): 3 patents
• C12N9/22 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 3 patents
• C12N15/102 ({Mutagenizing nucleic acids}): 3 patents
• C12N15/113 (Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; {Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing (when used in plants): 3 patents
• C07K2319/00 (PEPTIDES (peptides in foodstuffs): 3 patents
• C07K2319/43 (PEPTIDES (peptides in foodstuffs): 3 patents
• C07K2319/50 (PEPTIDES (peptides in foodstuffs): 3 patents
• C12N2310/20 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 3 patents
• C12N2740/10023 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 3 patents
• C12N2740/10042 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 3 patents
• C12N2740/13023 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 3 patents
• C12N2740/13042 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 3 patents
• C12N2800/80 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 3 patents

Companies

List of Companies

• Institut National De La Sante Et De La Recherche Medicale (INSERM): 3 patents

Collaborators

• Philippe MANGEOT (3 collaborations)
• Emiliano RICCI (3 collaborations)